198
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Risk factors affecting long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment for multiple uterine fibroids

, , , , , , , , , & show all
Article: 2365388 | Received 30 Nov 2023, Accepted 03 Jun 2024, Published online: 16 Jun 2024

References

  • Stewart E, Laughlin-Tommaso S, Catherino W, et al. Uterine fibroids. Nat Rev Dis Primers. 2016;2(1):1. doi: 10.1038/nrdp.2016.43.
  • Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Phys. 2007;75(10):1503–10.
  • Stewart E, Cookson C, Gandolfo R, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512. doi: 10.1111/1471-0528.14640.
  • Singh, Shikha, Kumar, Praveen, Rathore, Saurabh Singh, et al. Contemporary approaches in the management of uterine leiomyomas. Eur J Obstet Gynecol Reprod Biol 2023;287:195–210. doi: 10.1016/j.ejogrb.2023.06.021.
  • Cappelli A, Mosconi C, Cocozza M, et al. Uterine artery embolization for the treatment of symptomatic uterine fibroids of different sizes: a single center experience. J Pers Med. 2023;13(6):906. doi: 10.3390/jpm13060906.
  • Tsakos E, Xydias E, Ziogas A, et al. Multi-port robotic-assisted laparoscopic myomectomy: a systematic review and meta-analysis of comparative clinical and fertility outcomes. J Clin Med. 2023;12(12):4134. doi: 10.3390/jcm12124134.
  • Young R, Puma L, Latham M, et al. Radiofrequency ablation for treatment of leiomyomas: review of the manufacturer and user facility device experience (MAUDE) database. Obstet Gynecol. 2023;142(1):147–150. doi: 10.1097/AOG.0000000000005213.
  • Qin S, Lin Z, Liu N, et al. Prediction of postoperative reintervention risk for uterine fibroids using clinical-imaging features and T2WI radiomics before high-intensity focused ultrasound ablation. Int. J. Hypertherm. 2023;40(1):2226847. doi: 10.1080/02656736.2023.2226847.
  • Kociuba J, Łoziński T, Zgliczyńska M, et al. Occurrence of adverse events after magnetic resonance-guided high-intensity focused ultrasound (MR-USGHIFU) therapy in symptomatic uterine fibroids-a retrospective case-control study. Int. J. Hypertherm. 2023;40(1):2219436. doi: 10.1080/02656736.2023.2219436.
  • Xu J, Tang W, Lin L, et al. Post treatment and 3 month contrast enhanced MRI findings following USGHIFU of submucosal fibroids: a retrospective study. Int. J. Hypertherm. 2023;40(1):2216897. doi: 10.1080/02656736.2023.2216897.
  • Yuan Y, Xu W, Shen H, et al. Long-term outcomes of ultrasound guided high intensity focused ultrasound ablation for patients with uterine fibroids classified by T2WI: a multicenter retrospective study. Int. J. Hypertherm. 2023;40(1):2212887. doi: 10.1080/02656736.2023.2212887.
  • Wang Y, Gong C, He M, et al. Therapeutic dose and long-term efficacy of high-intensity focused ultrasound ablation for different types of uterine fibroids based on signal intensity on T2-weighted MR images. Int. J. Hypertherm. 2023;40(1):2194594. doi: 10.1080/02656736.2023.2194594.
  • Liu Y, Wu X, Wu A, et al. Ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids: long-term outcomes and factors affecting local recurrence. 2021;38(1):1341–1348.
  • Verpalen I, Anneveldt K, Nijholt I, et al. Magnetic resonance-high intensity focused ultrasound (MR-USGHIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis. Eur J Radiol. 2019;120:108700. doi: 10.1016/j.ejrad.2019.108700.
  • Liu L, Wang T, Lei B. High-intensity focused ultrasound (USGHIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis. Eur Radiol. 2022;32(2):1195–1204. doi: 10.1007/s00330-021-08156-6.
  • Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020;127(11):1422–1428. doi: 10.1111/1471-0528.16262.
  • Liu Y, Wu X, Wu A, et al. Ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids: long-term outcomes and factors affecting local recurrence. Int. J. Hypertherm. 2021;38(1):1341–1348. doi: 10.1080/02656736.2021.1973585.
  • Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids. Int. J. Hypertherm. 2020;37(1):1046–1051. doi: 10.1080/02656736.2020.1807617.
  • Li W, Yang Z, Gao B, et al. Comparison of ultrasound-guided high-intensity focused ultrasound ablation and hysteroscopic myomectomy for submucosal fibroids: a retrospective study. Int. J. Hypertherm. 2021;38(1):1609–1616. doi: 10.1080/02656736.2021.1995053.
  • Wang H, Yue Y, Zhou X, et al. Expression of vascular endothelial growth factor-receptor 1 and progesteronez receptor in patient with uterine leiomyoma (In Chinese). Chin. J. Lab. Diagnos. 2005;9(6):906–909.
  • Wei A, Ren M, Chen X, et al. Effects of mifepristone on expression of estrogen, progesterone receptor and epidermal growth factor receptor in cultured uterine fibroid cells (In Chinese). J. Southwest Univ. 2004;23(6):370–372.
  • Pan X. Clinical research on prevention of mifepristone to recurrence of uterine fibroids after myomectomy (In Chinese). China Modern Med. 2010;17(10):13–14.
  • Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196(2):184.e181-186–184.e6. doi: 10.1016/j.ajog.2006.08.030.
  • Zhao W, Chen J, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol. 2013;82(1):e43-49–e49. doi: 10.1016/j.ejrad.2012.08.020.
  • Zhao W, Zhang J, Han Z, et al. A clinical investigation treating different types of fibroids identified by MRI-T2WI imaging with ultrasound guided high intensity focused ultrasound. Sci Rep. 2017;7(1):10812. doi: 10.1038/s41598-017-11486-5.